Gartner, Inc. (IT) is now among the bigger bargains in its industry.
Within the last year the price ranged from $124.77 – 171.78 and there is a wide opportunity to get in. Its next earnings report will be released on Feb 04, 2020.
Regeneron Pharmaceuticals, Inc.(REGN)
move, based on 12 analysts offering 12 month price targets for Regeneron in the last 3 months. The average price target is $384.80 with a high forecast of $435.00 and a low forecast of $325.00. The average price target represents a -1.52% decrease from the last price of $390.75.
Analysts like Cory Kasimov from J.P. Morgan believe that we could see stock price minimum —.
Another prominent analyst, Dane Leone of Raymond James rates REGN as a Hold. The rating was made just 2 months ago.
Regeneron Pharmaceuticals, Inc.(REGN) Recent News Reports
On average 7.5 articles are written each week about REGN but this week 14 articles were written and they were 68% Bullish and 32% Bearish.
Regeneron Pharmaceuticals, Inc. Target Levels
The market experts are predicting that REGN is a Moderate Buy. Some other stocks to consider in this sector are: